http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-201290127-A1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-381 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D333-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D333-20 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-16 |
| filingDate | 2010-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2013-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EA-201290127-A1 |
| titleOfInvention | CRYSTALLIZATION METHOD (S) -N-METHYL-3- (1-NAFTYLOXY) -3- (2-THYENYL) PROPYLAMINE HYDROCHLORIDE (DULOXETHINE) |
| abstract | (S) -N-Methyl-3- (1-naphthyloxy) -3- (2-thienyl) propylamine hydrochloride of the formula I, crystallized in such a way that a suspension of duloxetine in a mixture of aprotic solvent and proton solvent is mixed at elevated temperature under conditions of simultaneous reduction volume fraction of protic solvent. |
| priorityDate | 2009-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 21.